Needham & Company Reiterates Buy Rating, $10 Price Target on Mereo BipPharma Group (MREO)
Tweet Send to a Friend
Needham & Company analyst Gil Blum reiterated a Buy rating and $10.00 price target on Mereo BipPharma Group (NASDAQ: MREO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
